Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review discusses the relationship between stress and skin disorders, highlighting psychodermatoses and recommending mind-body techniques and collaborative care involving dermatology, psychiatry, and psychology, without reporting new clinical results.

This article reviews the clinical features of dermatopathia pigmentosa reticularis, highlighting its characteristic triad of symptoms, but provides no new research results.

This review discusses post-SSRI sexual dysfunction and post-finasteride syndrome, highlighting unknowns about their true incidence and underlying causes, and reports no new clinical results.

Seborrheic dermatitis affects quality of life and sleep, linked to stress and nervous system changes.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Hair coloring and bleaching can permanently break down hair protein and temporarily change its properties.

This review discusses the pathophysiology of psoriasis and available treatment options but reports no clinical trial results.

This review observed limited evidence of clinically significant benefits from treatments for acute central serous chorioretinopathy, which often resolves spontaneously, but identified PDT and micropulse laser as the most promising for further trials.

This study found that the revised BASP classification for pattern hair loss, which addresses certain limitations of the original, could serve as an alternative option despite a decrease in clinical accuracy and ease of use.

This study resulted in a draft version of the Patient‐Reported Impact of Dermatological Diseases measure, PRIDD, which includes 27 items refined from patient consensus and is now undergoing psychometric testing.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

This research reexamined transcriptomic data to study stem and progenitor cell proliferation in psoriasis, finding that the number of committed progenitor cells increased eight-fold in psoriatic skin without altering stem cell numbers, potentially identifying new therapeutic targets.

This study suggests that erosive pustular dermatosis of the scalp may be part of the spectrum of autoinflammatory dermatoses, rather than a unique skin disorder.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

This policy brief found that post-drug syndromes are under-recognized in current pharmacovigilance systems, leading to inadequate risk assessments and prolonged patient harm from persistent drug-induced conditions.

This review highlights advancements in drug delivery systems for treating psoriasis and atopic dermatitis, focusing on their ability to enhance transdermal drug efficacy and safety by overcoming skin barriers and enabling precise, on-demand drug release at target sites.

This review discusses the mechanisms associated with protoporphyrin IX in living cells and reports no clinical results; the authors emphasize its potential in cancer diagnosis and the risks of toxicity.

This study investigated the histopathology of ectodermal dysplasia/skin fragility syndrome, identifying specific skin and hair abnormalities associated with PKP1 gene mutations in two young female patients.

This study investigated non-laser methods for removing permanent makeup using plant extracts, testing their decolorization effects on mice through tattooing and electroporation techniques.

This paper reviews the growing use of psychotropic drugs in dermatology due to the link between mental states and skin conditions but does not present new clinical findings.

A combined medical and aesthetic approach is crucial for effectively managing PCOS and its skin-related issues.

This study reported significant upregulation and release of S100A4 in psoriatic skin, which may actively contribute to psoriasis pathogenesis.

This article reviews the development and theories of psychosomatic concepts in dermatology, outlining classifications of psychocutaneous disease and suggesting improvements in clinical practice, without reporting new research results.

This study found high levels of anxiety, depression, and PTSD in dermatology patients one year after the February 6, 2023, earthquakes in Türkiye, with specific skin conditions like telogen effluvium and alopecia areata being more prevalent among those with psychological distress.

Pulsed dye laser and hydrogel dressings effectively treat hypertrophic scars.

Smart microneedles using advanced tech could improve psoriasis treatment.

This article describes erosive pustular dermatosis of the scalp, emphasizing its chronic nature, potential complications, and the lack of specific diagnostic findings, but reports no new clinical results.

This study found that psychological and social reporting after trauma with scarring can indicate a person's reaction and susceptibility to psychopathology.

PMS nanoparticles improve damaged hair by protecting and restoring its surface and color.

This research highlights advancements in understanding and treating psoriasis, finding that targeted therapies like IL-17 and IL-23 inhibitors show promise, but challenges such as adverse events, treatment resistance, and the need for personalized approaches remain.